NCT04788264
- Conditions
- Head and Neck Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Carcinoma, +37 more
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
Clinical trial condition
Stage IVA Laryngeal Cancer AJCC v8
Explore clinical trials studying Stage IVA Laryngeal Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
14 public trials
8 recruiting studies
Stage IVA Laryngeal Cancer AJCC v8 trial results
NCT04541355
- Conditions
- Carcinoma, Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Active, Not Recruiting
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT04862650
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
NCT04533750
- Conditions
- Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, +34 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States